Healthcare CFOs Struggle to Bridge Strategy and Execution Gap

The latest research from Deloitte highlights a widening rift between expectation and enablement within the C-suite. The most acute pressure points involve patient experience and affordability, where a 33-point readiness gap leaves many finance chiefs scrambling to align clinical goals with fiscal realities. Health systems appear particularly vulnerable, reporting a 38-point gap in these areas compared to 28 points for health plans. These challenges are compounded by the rising costs of specialty drugs and GLP-1 medications, a factor 85% of health plan leaders anticipate will hit margins hard, even as they remain largely underprepared to mitigate the impact.

Ambitious margin targets further complicate the landscape. Nearly 60% of surveyed finance leaders aim for at least 2 percentage points of growth over the next two years, yet only 47% believe their organizations possess the necessary tools to navigate the current climate. This pressure extends to technology investments, where AI adoption is outpacing the ability to quantify success. Although 44% of surveyed organizations have scaled GenAI deployments, only 18% of their CFOs consistently track the financial attribution of those investments. According to Jay Bhatt of the Deloitte Center for Health Solutions, the disconnect is likely an organizational design flaw that requires finance leaders to move beyond traditional stewardship and toward deeper integration with cross-functional strategic planning.